HPV vaccine

Pakistan is on the cusp of a major public health breakthrough. From September 15 to 27, the country will launch its first-ever national HPV vaccination campaign – an ambitious yet necessary initiative aimed at protecting millions of girls from cervical cancer, a disease that claims thousands of lives each year despite being almost entirely preventable. The numbers are staggering. Over 5,000 women in Pakistan are diagnosed with cervical cancer annually, and more than half of them do not survive. The disease is the second most common cancer among women in Pakistan, and among those aged 15 to 44, it ranks even higher. Yet the tragedy is not just the number of lives lost, but how preventable these deaths are through a safe, effective,and now freely available vaccine. The September campaign targets approximately 13 million girls aged 9 to 14 in Punjab, Sindh, Islamabad and Azad Jammu & Kashmir. The vaccine, provided in a single dose, offers lifelong protection and is backed by decades of research and global use. With the support of Gavi, the Vaccine Alliance, the doses will be administered through the Expanded Programme on Immunisation at no cost to families.

The scale and significance of this initiative cannot be overstated. It represents not just a public health measure but a social commitment to safeguarding the future of Pakistan’s girls. With 94 per cent of cervical cancer deaths occurring in low- and middle-income countries, the HPV vaccine will provide life-saving protection to those who need it most. The road ahead, however, is not without obstacles. Only three per cent of cancer patients in Pakistan are diagnosed at an early and treatable stage. The rest often face late-stage diagnoses, costly treatments and heartbreaking outcomes. Preventive measures like the HPV vaccine are therefore critical. But cultural taboos, misinformation and mistrust threaten to undermine progress. This is where the role of healthcare professionals, educators and civil society becomes indispensable. People generally trust doctors more than anyone else when it comes to vaccine safety. Their advocacy, especially in rural and underserved areas, can help dispel myths and build confidence in the vaccine.

The HPV vaccine will not only be administered in this initial 12-day campaign but will also be integrated into the national routine immunisation schedule. This is a long-term strategy, aiming to reach 18 million girls over the next three years. However, success hinges on more than logistics and will require widespread public awareness and a shift in societal attitudes. This is about giving girls the chance to grow into healthy women. In joining the ranks of over 140 countries that have already introduced the HPV vaccine, Pakistan is finally catching up. The campaign also aligns with WHO’s 90-70-90 goals for 2030: 90 per cent of girls vaccinated by age 15, 70 per cent of women screened and 90 per cent of those diagnosed receiving treatment. In this day and age, preventable diseases should no longer be fatal.